ACP5
Tartrate-resistant acid phosphatase type 5
Also known as: HPAP, PPA5_HUMAN, TRAcP, TRAP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13686
- Gene
- ACP5
- Ensembl
- ENSG00000102575
- Chromosome
- 19
- Canonical length
- 325 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes an iron containing glycoprotein which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. [provided by RefSeq, Aug 2008]
Canonical amino-acid sequenceUniProt
325 residues, UniProt reviewed canonical sequence.
>P13686|ACP5
1 MDMWTALLIL QALLLPSLAD GATPALRFVA VGDWGGVPNA PFHTAREMAN AKEIARTVQI
61 LGADFILSLG DNFYFTGVQD INDKRFQETF EDVFSDRSLR KVPWYVLAGN HDHLGNVSAQ
121 IAYSKISKRW NFPSPFYRLH FKIPQTNVSV AIFMLDTVTL CGNSDDFLSQ QPERPRDVKL
181 ARTQLSWLKK QLAAAREDYV LVAGHYPVWS IAEHGPTHCL VKQLRPLLAT YGVTAYLCGH
241 DHNLQYLQDE NGVGYVLSGA GNFMDPSKRH QRKVPNGYLR FHYGTEDSLG GFAYVEISSK
301 EMTVTYIEAS GKSLFKTRLP RRARPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACP5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 156 nTPM
Expression across tissuesHPA
Tissue
- lung: 156 nTPM
- lymph node: 67 nTPM
- kidney: 64 nTPM
- spleen: 53 nTPM
- stomach: 48 nTPM
- small intestine: 44 nTPM
Single-cell type
- macrophages: 252 nCPM
- esophageal apical cells: 182 nCPM
- retinal pigment epithelial cells: 149 nCPM
- kupffer cells: 110 nCPM
- hofbauer cells: 83 nCPM
- esophageal suprabasal cells: 80 nCPM
Immune cell
- memory B-cell: 173 nTPM
- naive B-cell: 92 nTPM
- eosinophil: 62 nTPM
- T-reg: 57 nTPM
- plasmacytoid DC: 48 nTPM
- non-classical monocyte: 32 nTPM
Brain region
- thalamus: 27 nTPM
- pons: 7.9 nTPM
- white matter: 6.3 nTPM
- hypothalamus: 3.5 nTPM
- spinal cord: 3.3 nTPM
- medulla oblongata: 2.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACP5.
Disease | AllUniProt
Conditions ACP5 is implicated in, by any mechanism.
- Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) MIM:607944
Disease | GeneticClinVar
38 pathogenic / likely-pathogenic of 345 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spondyloenchondrodysplasia with immune dysregulation
- Inborn genetic diseases
- ACP5-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone morphogenesis
- bone resorption
- defense response to Gram-positive bacterium
- negative regulation of inflammatory response
- negative regulation of interleukin-1 beta production
- negative regulation of interleukin-12 production
- negative regulation of macrophage cytokine production
- negative regulation of nitric oxide biosynthetic process
- negative regulation of superoxide anion generation
- negative regulation of tumor necrosis factor production
- nitric oxide biosynthetic process
- response to cytokine
- response to lipopolysaccharide
- superoxide anion generation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Calcineurin-like, phosphoesterase domain
- Metallo-dependent phosphatase-like
- Calcineurin-like phosphoesterase
- Purple acid phosphatase
- Metallophosphoesterase Purple Acid Phosphatase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACP5 as an antibody target. Whether an autoantibody or antibody against ACP5 could matter depends on whether native ACP5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACP5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACP5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...